title: Lyme disease vaccination: safety first - authors' reply.
authors.affiliation: Vaccine R&D, Biomedical Research Centre, Baxter Bioscience, Uferstraße 15, A-2304 Orth/Donau, Austria. Electronic address: noel_barrett@baxter.com.
authors.forename: P Noel
authors.initials: PN
authors.lastname: Barrett
authors.affiliation: Vaccine R&D, Biomedical Research Centre, Baxter Bioscience, Uferstraße 15, A-2304 Orth/Donau, Austria.
authors.forename: Brian A
authors.initials: BA
authors.lastname: Crowe
authors.affiliation: Vaccine R&D, Baxter Bioscience, Vienna, Austria.
authors.forename: Nina
authors.initials: N
authors.lastname: Wressnigg
authors.affiliation: Vaccine R&D, Biomedical Research Centre, Baxter Bioscience, Uferstraße 15, A-2304 Orth/Donau, Austria.
authors.forename: Daniel
authors.initials: D
authors.lastname: Portsmouth
authors.affiliation: Vaccine R&D, Baxter Bioscience, Vienna, Austria.
authors.forename: Gerald
authors.initials: G
authors.lastname: Aichinger
mesh_terms: D000276:Adjuvants, Immunologic / Q000009:adverse effects*; D000954:Antigens, Surface / Q000009:adverse effects* / Q000276:immunology*; D001425:Bacterial Outer Membrane Proteins / Q000009:adverse effects* / Q000276:immunology*; D001428:Bacterial Vaccines / Q000009:adverse effects* / Q000276:immunology*; D025065:Borrelia burgdorferi / Q000276:immunology*; D005260:Female; D006801:Humans; D008074:Lipoproteins / Q000009:adverse effects* / Q000276:immunology*; D022123:Lyme Disease Vaccines / Q000009:adverse effects* / Q000276:immunology*; D008297:Male
chemical_list: D000276:Adjuvants, Immunologic; D000954:Antigens, Surface; D001425:Bacterial Outer Membrane Proteins; D001428:Bacterial Vaccines; D008074:Lipoproteins; D022123:Lyme Disease Vaccines